LSL Pharma Group Inc. (TSXV:LSL)
Canada · Delayed Price · Currency is CAD 0.3700
-0.0050 (-1.33%)
Sep 10, 2025, 3:00 PM EDT
LSL Pharma Group Revenue
LSL Pharma Group had revenue of 7.22M CAD in the quarter ending June 30, 2025, with 72.23% growth. This brings the company's revenue in the last twelve months to 23.24M, up 62.22% year-over-year. In the year 2024, LSL Pharma Group had annual revenue of 17.75M with 76.98% growth.
Revenue (ttm)
23.24M
Revenue Growth
+62.22%
P/S Ratio
1.93
Revenue / Employee
125.61K
Employees
186
Market Cap
44.85M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 17.75M | 7.72M | 76.98% |
| Dec 31, 2023 | 10.03M | 1.81M | 22.08% |
| Dec 31, 2022 | 8.21M | -557.15K | -6.35% |
| Dec 31, 2021 | 8.77M | -1.28M | -12.70% |
| Dec 31, 2020 | 10.05M | 5.22M | 108.32% |
| Oct 3, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Curaleaf Holdings | 1.75B |
| Green Thumb Industries | 1.57B |
| Trulieve Cannabis | 1.62B |
| Sienna Senior Living | 929.68M |
| dentalcorp Holdings | 1.62B |
| Cronos Group | 177.69M |
| WELL Health Technologies | 1.12B |
| Extendicare | 1.51B |